Feedback / Questions
fosciclopirox (ciclopirox prodrug) - BioNOVUS, University of Kansas Medical Center
http://www.globenewswire.com/news-release/2019/12/03/1955636/0/en/CicloMed-Expands-Fosciclopirox-Phase-1-Trial-to-Include-Cisplatin-Ineligible-Muscle-Invasive-Bladder-Cancer-Patients.html
Dec 4, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next